These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 7062445)

  • 41. Urinary supersaturation with respect to brushite in patients suffering calcium oxalate lithiasis.
    Berland Y; Boistelle R; Olmer M
    Nephrol Dial Transplant; 1990; 5(3):179-84. PubMed ID: 2113644
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The role of macromolecules in the formation of kidney stones.
    Rimer JD; Kolbach-Mandel AM; Ward MD; Wesson JA
    Urolithiasis; 2017 Feb; 45(1):57-74. PubMed ID: 27913854
    [TBL] [Abstract][Full Text] [Related]  

  • 43. On the catalysis of calcium oxalate dihydrate formation by osteopontin peptides.
    Chan BP; Vincent K; Lajoie GA; Goldberg HA; Grohe B; Hunter GK
    Colloids Surf B Biointerfaces; 2012 Aug; 96():22-8. PubMed ID: 22503630
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The dual role of polyelectrolytes and proteins as mineralization promoters and inhibitors of calcium oxalate monohydrate.
    Campbell AA; Ebrahimpour A; Perez L; Smesko SA; Nancollas GH
    Calcif Tissue Int; 1989 Aug; 45(2):122-8. PubMed ID: 2476205
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A study of the phase transformation of calcium oxalate trihydrate-monohydrate.
    Tomazic BB; Nancollas GH
    Invest Urol; 1979 Mar; 16(5):329-35. PubMed ID: 429126
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Adhesion and endocytosis of calcium oxalate crystals on renal tubular cells.
    Kohjimoto Y; Ebisuno S; Tamura M; Ohkawa T
    Scanning Microsc; 1996; 10(2):459-68; discussion 468-70. PubMed ID: 9813624
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Intracrystalline proteins and urolithiasis: a comparison of the protein content and ultrastructure of urinary calcium oxalate monohydrate and dihydrate crystals.
    Ryall RL; Chauvet MC; Grover PK
    BJU Int; 2005 Sep; 96(4):654-63. PubMed ID: 16104927
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Factors affecting the regrowth of renal stones in vitro: a contribution to the understanding of renal stone development.
    Costa-Bauzá A; Isern B; Perelló J; Sanchis P; Grases F
    Scand J Urol Nephrol; 2005; 39(3):194-9. PubMed ID: 16118089
    [TBL] [Abstract][Full Text] [Related]  

  • 49. An understanding of renal stone development in a mixed oxalate-phosphate system.
    Guan X; Wang L; Dosen A; Tang R; Giese RF; Giocondi JL; Orme CA; Hoyer JR; Nancollas GH
    Langmuir; 2008 Jul; 24(14):7058-60. PubMed ID: 18557638
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Triamterene calculus.
    Dickstein ES; Loeser WD
    J Urol; 1985 Jun; 133(6):1019. PubMed ID: 3999199
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The kinetics of crystallization of calcium oxalate trihydrate.
    Sheehan ME; Nancollas GH
    J Urol; 1984 Jul; 132(1):158-63. PubMed ID: 6726950
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Do "inhibitors of crystallisation" play any role in the prevention of kidney stones? A critique.
    Robertson WG
    Urolithiasis; 2017 Feb; 45(1):43-56. PubMed ID: 27900407
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Contribution of human uropontin to inhibition of calcium oxalate crystallization.
    Asplin JR; Arsenault D; Parks JH; Coe FL; Hoyer JR
    Kidney Int; 1998 Jan; 53(1):194-9. PubMed ID: 9453018
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Calcium phosphate/calcium oxalate crystal association in urinary stones: implications for heterogeneous nucleation of calcium oxalate.
    Khan SR
    J Urol; 1997 Jan; 157(1):376-83. PubMed ID: 8976301
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Triamterene and renal lithiasis: a review.
    Carey RA; Beg MM; McNally CF; Tannenbaum P
    Clin Ther; 1984; 6(3):302-9. PubMed ID: 6373008
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Enlargement of a lower pole calcium oxalate stone: a theoretical examination of the role of crystal nucleation, growth, and aggregation.
    Kavanagh JP
    J Endourol; 1999 Nov; 13(9):605-10. PubMed ID: 10608510
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Uric acid as inducer of calcium oxalate crystal development.
    Grases F; Sanchis P; Isern B; Perelló J; Costa-Bauzá A
    Scand J Urol Nephrol; 2007; 41(1):26-31. PubMed ID: 17366099
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The osteopontin-controlled switching of calcium oxalate monohydrate morphologies in artificial urine provides insights into the formation of papillary kidney stones.
    Langdon A; Grohe B
    Colloids Surf B Biointerfaces; 2016 Oct; 146():296-306. PubMed ID: 27362921
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Annexin II is present on renal epithelial cells and binds calcium oxalate monohydrate crystals.
    Kumar V; Farell G; Deganello S; Lieske JC
    J Am Soc Nephrol; 2003 Feb; 14(2):289-97. PubMed ID: 12538728
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Human kidney stone matrix: Latent potential to restrain COM induced cytotoxicity and inflammatory response.
    Narula S; Tandon S; Baligar P; Singh SK; Tandon C
    Chem Biol Interact; 2017 Dec; 278():114-122. PubMed ID: 29054323
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.